‹ All stocks
Lite Strategy
LITS · NASDAQ · Financial Services
$1.42
▲ $1.42 (1.43%)
Day range
$1.38 – $1.43
Year range
$0.69 – $2.97
Open
$1.40
Previous close
—
Market cap
$48.32M
Volume (24h)
$108.9K
Volume (52w)
$154.66K
Performance
7D
▲ 4.41%
1M
▲ 29.09%
3M
▲ 46.21%
6M
▲ 24.56%
1Y
▼ -45.38%
YTD
▼ -7.79%
3Y
▼ -68.65%
5Y
▼ -68.65%
All-time
▼ -68.65%
Key statistics
P/E ratio
-0.72
EPS (TTM)
$-1.98
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
34.0M
About Lite Strategy
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$504.31 | 0.45% |
JPM JPMorgan Chase & Co. |
$332.42 | -0.27% |
V Visa |
$365.05 | 1.41% |
MA Mastercard Incorporated |
$561.12 | 1.64% |
BAC Bank of America |
$54.10 | 0.11% |